Erratum: Antivirals become a broader enterprise

The Original Article was published on 01 December 2007

Nat. Biotechnol. 25, 1395–1402; published online December 7, 2007; corrected after print 8 April 2008.

In the version of this article initially published, the name of a person quoted on p. 1399 was incorrect. The CSO of Replicor of Laval, QC, Canada, given as “Andrew Toussaint” should be “Andrew Vaillant.” The error has been corrected in the HTML and PDF versions of the article.

Authors

Additional information

The online version of the original article can be found at 10.1038/nbt1207-1395

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fox, J. Erratum: Antivirals become a broader enterprise. Nat Biotechnol 26, 709 (2008). https://doi.org/10.1038/nbt0608-709b

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing